PERSONAL DETAILS
Name: Cremolini, Chiara
Place and Date of birth: La Spezia, Italy, 26th February 1984
Nationality: Italian
EDUCATION AND QUALIFICATION
02/2017 Present: Assistant Professor in Medical Oncology at University of Pisa. Teaching, tutoring activity for undergraduate students and residents, and clinical activity at Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
01/2017 Present: Member of the Faculty of the European Society of Medical Oncology for Gastrointestinal Cancers
01/2017 Present: Member of the Committee for the development of Colorectal Cancer Clinical Guidelines by the Associazione Italiana di Oncologia Medica (AIOM)
11/2015 Present: Scientific Secretary of the cooperative group for research GONO (Gruppo Oncologico del Nord Ovest)
11/2014-04/2018: PhD in Clinical Pathophysiology at University of Pisa, Pisa, Italy. Thesis:
10/2011-10/2015: Member of the National Working Group of Young Oncologists of the Italian Association of Medical Oncology.
07/2009-06/2014: Fellowship Training Program in Medical Oncology at University of Pisa, Pisa, Italy Azienda Ospedaliero-Universitaria Pisana. Director: Prof. A. Falcone, Full Professor in Medical Oncology. Final grade: 110/110 cum laude. Thesis: FOLFOXIRI plus bevacizumab as initial treatment for metastatic colorectal cancer: results of the phase III TRIBE trial.
02/2012: European Society of Medical Oncology (ESMO) Translational Research Unit Visit at Institute Gustave Roussy.
12/2011: Visiting student at University of Southern California Norris Comprehensive Cancer Center at Dr.Heinz-Josef Lenz Lab.
01/2011: Second-level master in Clinical trials on drugs at University of Pisa, Department of Clinical Pharmacology.
02/2009-Present: Qualifying Examination to the profession of physician and subscription to the Register of Physicians and Dentists
09/2002-10/2009: Undergraduate Student attending second-level degree in Medical Sciences, SantAnna School for advanced Studies, Pisa, Italy. Final grade 100/100 cum laude. Thesis: Retrospective study about the role of BRAF mutation and AR expression in the treatment of metastatic colorectal cancer patients with cetuximab and irinotecan. Supervisors: Prof. A. Falcone, Dr. F. Loupakis, Prof. F.A. Recchia.
09/2002-09/2008: Undergraduate Student attending Laurea Specialistica (MD) in Medicine and Surgery. University of Pisa, Pisa, Italy. Final grade: 110/110 cum laude. Thesis: Retrospective study about the role of KRAS mutations and PTEN immunohistochemical expression as predictors of benefit from cetuximab plus irinotecan in metastatic colorectal cancer. Supervisors: Prof. A. Falcone, Dr. F. Loupakis.
10-11/2006: Visiting Student at Cornell University (New York, NY) and Harvard University-Harvard Medical School (Boston, MA).
09/1997-07/2002: Student attending Liceo Classico L.Costa, La Spezia, Italy, awarding the high-school degree. Final grade: 100/100. Main subjects: Italian Literature, Latin, Greek, Philosofy.